Cancer Cell

• 

  Publication Venue For

  • Human Tumor-Associated Macrophage and Monocyte Transcriptional Landscapes Reveal Cancer-Specific Reprogramming, Biomarkers, and Therapeutic Targets..  35:588-602.e10. 2019
  • Serine and Methionine Metabolism: Vulnerabilities in Lethal Prostate Cancer..  35:339-341. 2019
  • Disruption of the β1L Isoform of GABP Reverses Glioblastoma Replicative Immortality in a TERT Promoter Mutation-Dependent Manner.  34:513-528.e8. 2018
  • Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients.  34:211-224.e6. 2018
  • Biological Role and Therapeutic Potential of IDH Mutations in Cancer..  34:186-195. 2018
  • A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers..  33:690-705.e9. 2018
  • Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas..  33:721-735.e8. 2018
  • Genomic and Functional Approaches to Understanding Cancer Aneuploidy..  33:676-689.e3. 2018
  • lncRNA Epigenetic Landscape Analysis Identifies EPIC1 as an Oncogenic lncRNA that Interacts with MYC and Promotes Cell-Cycle Progression in Cancer..  33:706-720.e9. 2018
  • Glucose Metabolism in Cancer: The Saga of Pyruvate Kinase Continues..  33:337-339. 2018
  • Neomorphic ERα Mutations Drive Progression in Breast Cancer and Present a Challenge for New Drug Discovery..  33:153-155. 2018
  • Genomic and Epigenomic Profiling of High-Risk Intestinal Metaplasia Reveals Molecular Determinants of Progression to Gastric Cancer..  33:137-150.e5. 2018
  • ACTL6A Is Co-Amplified with p63 in Squamous Cell Carcinoma to Drive YAP Activation, Regenerative Proliferation, and Poor Prognosis..  31:35-49. 2017
  • CD98-Mediated Adhesive Signaling Enables the Establishment and Propagation of Acute Myelogenous Leukemia..  30:792-805. 2016
  • RIPK3 Slams the Brake on Leukemogenesis..  30:7-9. 2016
  • N-Myc Drives Neuroendocrine Prostate Cancer Initiated from Human Prostate Epithelial Cells.  29:536-547. 2016
  • MiR-215 Is Induced Post-transcriptionally via HIF-Drosha Complex and Mediates Glioma-Initiating Cell Adaptation to Hypoxia by Targeting KDM1B..  29:49-60. 2016
  • Erythropoietin Stimulates Tumor Growth via EphB4..  28:610-622. 2015
  • Inhibition of Spleen Tyrosine Kinase Potentiates Paclitaxel-Induced Cytotoxicity in Ovarian Cancer Cells by Stabilizing Microtubules..  28:82-96. 2015
  • Targeting ABL1-mediated oxidative stress adaptation in fumarate hydratase-deficient cancer..  26:840-850. 2014
  • Macrophage IL-10 blocks CD8+ T cell-dependent responses to chemotherapy by suppressing IL-12 expression in intratumoral dendritic cells..  26:623-637. 2014
  • RAS and ROS in rhabdomyosarcoma..  24:689-691. 2013
  • Par-4 downregulation promotes breast cancer recurrence by preventing multinucleation following targeted therapy..  24:30-44. 2013
  • Releasing the block: setting differentiation free with mutant IDH inhibitors..  23:570-572. 2013
  • In vivo imaging of tumor-propagating cells, regional tumor heterogeneity, and dynamic cell movements in embryonal rhabdomyosarcoma..  21:680-693. 2012
  • An animal model of MYC-driven medulloblastoma..  21:155-167. 2012
  • TGF-β-miR-34a-CCL22 Signaling-Induced Treg Cell Recruitment Promotes Venous Metastases of HBV-Positive Hepatocellular Carcinoma.  22:291-303. 2012
  • The metabolic regulator ERRα, a downstream target of HER2/IGF-1R, as a therapeutic target in breast cancer..  20:500-510. 2011
  • Cell Autonomous Role of PTEN in Regulating Castration-Resistant Prostate Cancer Growth.  19:792-804. 2011
  • Nonreceptor tyrosine kinase BMX maintains self-renewal and tumorigenic potential of glioblastoma stem cells by activating STAT3..  19:498-511. 2011
  • IDH1 and IDH2: not your typical oncogenes..  17:215-216. 2010
  • Somatic single hits inactivate the X-linked tumor suppressor FOXP3 in the prostate..  16:336-346. 2009
  • Identification of CD15 as a Marker for Tumor-Propagating Cells in a Mouse Model of Medulloblastoma (DOI:10.1016/j.ccr.2008.12.016).  16:267. 2009
  • AKT-independent signaling downstream of oncogenic PIK3CA mutations in human cancer..  16:21-32. 2009
  • Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells..  15:501-513. 2009
  • Tumor vasculature is regulated by PHD2-mediated angiogenesis and bone marrow-derived cell recruitment..  15:527-538. 2009
  • Gli2 and p53 Cooperate to Regulate IGFBP-3- Mediated Chondrocyte Apoptosis in the Progression from Benign to Malignant Cartilage Tumors.  16:126-136. 2009
  • Loss of beta-catenin impairs the renewal of normal and CML stem cells in vivo..  12:528-541. 2007
  • Ultraconserved regions encoding ncRNAs are altered in human leukemias and carcinomas..  12:215-229. 2007
  • Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma..  12:115-130. 2007
  • RXR is an essential component of the oncogenic PML/RARA complex in vivo..  12:23-35. 2007
  • Targeted expression of BikDD eradicates pancreatic tumors in noninvasive imaging models..  12:52-65. 2007
  • Tribbles homolog 2 inactivates C/EBPalpha and causes acute myelogenous leukemia..  10:401-411. 2006
  • mILC-ing the mouse mammary gland: A model for invasive lobular carcinoma..  10:347-349. 2006
  • Reduction in the requirement of oncogenic Ras signaling to activation of PI3K/AKT pathway during tumor maintenance.  8:381-392. 2005
  • Reduction in the requirement of oncogenic Ras signaling to activation of PI3K/AKT pathway during tumor maintenance..  8:381-392. 2005
  • Pleiotropic effects of HIF-1 blockade on tumor radiosensitivity..  8:99-110. 2005
  • Activation of RalA is critical for Ras-induced tumorigenesis of human cells..  7:533-545. 2005
  • Protein farnesyltransferase in embryogenesis, adult homeostasis, and tumor development..  7:313-324. 2005
  • The convergence of cancer prevention and therapy in early-phase clinical drug development..  6:321-326. 2004
  • Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors: role of reoxygenation, free radicals, and stress granules..  5:429-441. 2004
  • Periostin potently promotes metastatic growth of colon cancer by augmenting cell survival via the Akt/PKB pathway..  5:329-339. 2004
  • Developmental biology informs cancer: the emerging role of the hedgehog signaling pathway in upper gastrointestinal cancers..  4:245-247. 2003
  • Genomic amplification and oncogenic properties of the KCNK9 potassium channel gene..  3:297-302. 2003
  • Optimal gene expression analysis by microarrays..  2:353-361. 2002
  • ITF-2, a downstream target of the Wnt/TCF pathway, is activated in human cancers with beta-catenin defects and promotes neoplastic transformation..  1:145-155. 2002
  • Germline Genetic IKZF1 Variation and Predisposition to Childhood Acute Lymphoblastic Leukemia. 2018